Earnings call transcript: Kajaria Ceramics posts Q2 2026 beat on sales, profit

Kajaria Ceramics reported Q2 FY2027 revenue of ₹14.68 billion, up 24% year over year, and profit after tax of ₹1.90 billion, up 42.9%; EBITDA margin expanded to 19.5% from 17.94%. EPS of 11.1 beat the 10.78 forecast, while revenue modestly exceeded estimates, but shares fell 1.24% to $1,122.5. Management expects double-digit volume growth over the next two quarters and into FY2028, with margins around current levels and no near-term price hikes; Srikalahasti and Gailpur expansions are on track to add capacity by around June 2027.

Analysis

The investment case is less about a one-quarter earnings beat than whether Kajaria can turn Morbi’s cost shock into durable share gains. Its strategic choice to hold the price gap narrower and prioritize volume transfers some potential margin upside to customers; the payoff depends on repeat purchases and dealer sell-through, not just shipments. Verify channel inventory and receivables before treating management’s market-share claims as structural.

The second-order exposure cuts both ways: Morbi disruption improves Kajaria’s relative cost position, but Kajaria still relies on Morbi outsourcing. A quick normalization in fuel availability or prices could restore competitors’ pricing power before Kajaria’s own brownfield capacity is commissioned. The new plants may lower unit and freight costs over time, but capacity ramp-up, added fixed costs, and higher advertising spend can absorb those benefits. Management’s stable-margin stance also limits the case for paying for near-term margin expansion.

Near term, the modest post-results decline and small estimate beat do not establish a mispricing; valuation and relative-performance data are missing. Over 1–3 months, monitor gas/propane prices, Morbi operating capacity, volume versus industry growth, and working-capital conversion. Over 6–18 months, commissioning and utilization—not announced capacity—will determine whether outsourcing falls and incremental returns justify capex. Contrarian point: this is a distribution-and-cost-positioning thesis, not a clean real-assets inflation hedge. It weakens if Morbi supply recovers, Kajaria’s volume growth converges with the market, or margins fall below the guided range. No company identities or tickers were supplied, so avoid ticker-level or valuation-specific conclusions.

Key Decisions for Investors

• Do not chase the quarter as a standalone catalyst. Consider a staged long in Kajaria Ceramics only on weakness, after checking valuation, dealer sell-through, and cash conversion; keep sizing modest until the volume gains are independently supported.
• Treat Morbi supply disruption as a near-term catalyst, not a permanent competitive moat. Reassess if fuel costs ease or Morbi capacity returns and Kajaria’s pricing advantage narrows.
• Track the next two quarters for volume growth relative to the market, working-capital days, and outsourcing levels. Falsification: company volume growth falls to market levels, working capital deteriorates materially, or EBITDA margin slips below the roughly 19% level management is targeting.
• Keep the brownfield capacity thesis on watch through the expected commissioning window. Require evidence of on-time start-up, utilization, and lower outsourced volume before underwriting structural margin or return improvement; compare Somany Ceramics only after reviewing relative valuation and operating disclosures.